| Literature DB >> 30046962 |
Kaitlin Grosgebauer1, Jessica Salinas1, Mark Sharkey1, Margaret Roach1, Suresh Pallikkuth1, Samantha E Dilworth2, Savita Pahwa1, Tulay Koru-Sengul1, Mario Stevenson1, Adam W Carrico3,4.
Abstract
This cross-sectional study investigated the associations of psychosocial factors relevant to recovery from substance use disorders with monocyte activation and HIV persistence in a sample of 84 HIV-positive, methamphetamine-using sexual minority men with undetectable HIV viral load (<40 copies/mL). We examined if psychosocial factors were associated with decreased soluble CD14 (sCD14) and lower proviral HIV DNA. Multiple linear regression models adjusted for age, anti-retroviral therapy regimen, and CD4+ T-cell count. Time on ART was also included in models examining proviral HIV DNA. Greater self-efficacy for managing methamphetamine triggers and higher social support for abstinence were independently associated with lower sCD14. Greater social support for abstinence was also independently associated with lower proviral HIV DNA. Psychosocial factors relevant to recovery from substance use disorders are associated with lower monocyte activation and decreased proviral HIV DNA. Findings underscore the need for longitudinal research to identify plausible mechanisms linking psychosocial factors and substance use with biological processes relevant to HIV pathogenesis.Entities:
Keywords: HIV persistence; Immune activation; Methamphetamine; Self-efficacy; Social support
Year: 2018 PMID: 30046962 PMCID: PMC6347547 DOI: 10.1007/s11481-018-9797-2
Source DB: PubMed Journal: J Neuroimmune Pharmacol ISSN: 1557-1890 Impact factor: 4.147